Goldman Sachs Group Inc. Sells 605,293 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Goldman Sachs Group Inc. decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 51.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 578,707 shares of the company’s stock after selling 605,293 shares during the period. Goldman Sachs Group Inc.’s holdings in Option Care Health were worth $19,497,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Principal Securities Inc. bought a new stake in shares of Option Care Health during the 4th quarter valued at $27,000. Parallel Advisors LLC grew its position in shares of Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after acquiring an additional 478 shares during the period. TFO Wealth Partners LLC grew its position in shares of Option Care Health by 24,625.0% during the 4th quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after acquiring an additional 985 shares during the period. Parkside Financial Bank & Trust boosted its holdings in Option Care Health by 24,250.0% in the 4th quarter. Parkside Financial Bank & Trust now owns 2,922 shares of the company’s stock worth $98,000 after buying an additional 2,910 shares during the period. Finally, International Assets Investment Management LLC boosted its holdings in Option Care Health by 1,513.7% in the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock worth $103,000 after buying an additional 2,876 shares during the period. Institutional investors own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on OPCH shares. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 24th. Jefferies Financial Group upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Stock Down 0.1 %

OPCH opened at $28.12 on Thursday. The firm has a 50-day simple moving average of $29.43 and a two-hundred day simple moving average of $31.33. Option Care Health, Inc. has a 52 week low of $26.17 and a 52 week high of $35.74. The company has a market capitalization of $4.89 billion, a PE ratio of 18.50, a price-to-earnings-growth ratio of 1.37 and a beta of 1.31. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The business had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the prior year, the firm earned $0.21 EPS. The business’s revenue was up 12.8% on a year-over-year basis. Analysts forecast that Option Care Health, Inc. will post 1.19 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.